JUVE Patent

Daniel Lim


Kirkland & Ellis

Kirkland & Ellis International LLP
EC3A 8AF London
United Kingdom
phone_icon Created with Sketch. +44 20 7469 2214
envelope_icon Created with Sketch. daniel.lim@kirkland.com

Expertise

Biotechnology, Chemistry, Medical Devices, Pharmaceuticals

About Daniel Lim

Daniel is a partner in Kirkland’s IP litigation team in London. Daniel has a broad practice which covers a wide range of technical fields, but is particularly noted for his expertise in life sciences patent litigation, particularly in the pharmaceutical industry, diagnostics and the emerging fields of precision medicine and cell and gene therapy. He is also experienced in representing clients involved in complex Standard Essential Patent and FRAND licensing disputes.

In addition to UK litigation, Daniel is regularly called upon to assist clients in devising, coordinating and executing patent strategies for complex multijurisdictional disputes at a pan-European and global scale. With dual qualifications in law and biochemistry, and experience litigating in multiple jurisdictions around the world, Daniel is readily able to grasp highly technical material and the international dimensions of disputes which are often at the heart of effective strategies in blockbuster litigation for the most sophisticated clients.

Daniel is recognised as a thought leader and regular writer, speaker and commentator on a wide range of topics relating to the life sciences industry and IP generally, notably including the rising gene editing technology CRISPR. Testament to his standing and leadership in the IP community, Daniel currently serves as the Vice-Chair of two standing committees of the International Association for the Protection of Intellectual Property (AIPPI): the Biotechnology committee as well as the committee on IP and Genetic Resources and Traditional Knowledge.

Daniel has recently been described in IAM Patent 1000 as a “Life sciences genius with the ability to quickly unpick the most arcane biochemistry issues

Awards

  • World Intellectual Property Review Leader 2020
  • Listed in IAM Strategy 300 and IAM Patent 2020
  • Rising Star in Life Sciences 2019 by Expert Guides
  • Winner in the UK and Life Sciences categories at the Euromoney Legal Media Group Europe Rising Stars Awards 2019
  • Rising Star by Managing Intellectual Property 2017 and 2018

Publications

More experts at Kirkland & Ellis